These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Activation of innate immune responses in a pathogen-mimicking manner by amphiphilic polyanhydride nanoparticle adjuvants. Petersen LK; Ramer-Tait AE; Broderick SR; Kong CS; Ulery BD; Rajan K; Wannemuehler MJ; Narasimhan B Biomaterials; 2011 Oct; 32(28):6815-22. PubMed ID: 21703679 [TBL] [Abstract][Full Text] [Related]
13. Enhanced in vivo targeting of murine nonparenchymal liver cells with monophosphoryl lipid A functionalized microcapsules. Pietrzak-Nguyen A; Fichter M; Dedters M; Pretsch L; Gregory SH; Meyer C; Doganci A; Diken M; Landfester K; Baier G; Gehring S Biomacromolecules; 2014 Jul; 15(7):2378-88. PubMed ID: 24901387 [TBL] [Abstract][Full Text] [Related]
14. Multi-functional nanocomplex codelivery of Trp2 and R837 to activate melanoma-specific immunity. Ji Z; Tan Z; Li M; Tao J; Guan E; Du J; Hu Y Int J Pharm; 2020 May; 582():119310. PubMed ID: 32276088 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and Characterization of Rapidly Degrading Polyanhydrides as Vaccine Adjuvants. Kelly SM; Mitra A; Mathur S; Narasimhan B ACS Biomater Sci Eng; 2020 Jan; 6(1):265-276. PubMed ID: 33463223 [TBL] [Abstract][Full Text] [Related]
16. Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A. Idoyaga J; Lubkin A; Fiorese C; Lahoud MH; Caminschi I; Huang Y; Rodriguez A; Clausen BE; Park CG; Trumpfheller C; Steinman RM Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2384-9. PubMed ID: 21262813 [TBL] [Abstract][Full Text] [Related]
17. Lipid-based vaccine nanoparticles for induction of humoral immune responses against HIV-1 and SARS-CoV-2. Park KS; Bazzill JD; Son S; Nam J; Shin SW; Ochyl LJ; Stuckey JA; Meagher JL; Chang L; Song J; Montefiori DC; LaBranche CC; Smith JL; Xu J; Moon JJ J Control Release; 2021 Feb; 330():529-539. PubMed ID: 33358977 [TBL] [Abstract][Full Text] [Related]
18. The differences in immunoadjuvant mechanisms of TLR3 and TLR4 agonists on the level of antigen-presenting cells during immunization with recombinant adenovirus vector. Lebedeva E; Bagaev A; Pichugin A; Chulkina M; Lysenko A; Tutykhina I; Shmarov M; Logunov D; Naroditsky B; Ataullakhanov R BMC Immunol; 2018 Jul; 19(1):26. PubMed ID: 30055563 [TBL] [Abstract][Full Text] [Related]
19. Rational design of pathogen-mimicking amphiphilic materials as nanoadjuvants. Ulery BD; Petersen LK; Phanse Y; Kong CS; Broderick SR; Kumar D; Ramer-Tait AE; Carrillo-Conde B; Rajan K; Wannemuehler MJ; Bellaire BH; Metzger DW; Narasimhan B Sci Rep; 2011; 1():198. PubMed ID: 22355713 [TBL] [Abstract][Full Text] [Related]
20. N-glycosylation converts non-glycoproteins into mannose receptor ligands and reveals antigen-specific T cell responses in vivo. Kreer C; Kuepper JM; Zehner M; Quast T; Kolanus W; Schumak B; Burgdorf S Oncotarget; 2017 Jan; 8(4):6857-6872. PubMed ID: 28036287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]